These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 6167418)

  • 1. Ribavirin and inosiplex: a review of their present status in viral diseases.
    Chang TW; Heel RC
    Drugs; 1981 Aug; 22(2):111-28. PubMed ID: 6167418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunomodulatory action of inosiplex in relation to its effects in experimental viral infections.
    Ohnishi H; Kosuzume H; Inaba H; Ohkura M; Shimada S; Suzuki Y
    Int J Immunopharmacol; 1983; 5(3):181-96. PubMed ID: 6194125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Virus diseases treated with isoprinosine and ribavirin (author's transl)].
    Propper P; Kopecký J
    Cas Lek Cesk; 1982 Jan; 121(1):22-4. PubMed ID: 6173129
    [No Abstract]   [Full Text] [Related]  

  • 4. Ribavirin: a clinical overview.
    Fernandez H; Banks G; Smith R
    Eur J Epidemiol; 1986 Mar; 2(1):1-14. PubMed ID: 3021519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical review of ribavirin.
    Eggleston M
    Infect Control; 1987 May; 8(5):215-8. PubMed ID: 3298116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic efficacy of inosiplex (Isoprinosine) in rhinovirus infection.
    Waldman RH; Ganguly R
    Ann N Y Acad Sci; 1977 Mar; 284():153-60. PubMed ID: 81636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inosine pranobex. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
    Campoli-Richards DM; Sorkin EM; Heel RC
    Drugs; 1986 Nov; 32(5):383-424. PubMed ID: 2431857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ribavirin.
    Conner CS
    Drug Intell Clin Pharm; 1984 Feb; 18(2):137-8. PubMed ID: 6697874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inosiplex in recurrent herpes simplex infection.
    Abeles JH
    Lancet; 1982 Oct; 2(8304):926. PubMed ID: 6181365
    [No Abstract]   [Full Text] [Related]  

  • 10. Mechanism of host defense suppression induced by viral infection: mode of action of inosiplex as an antiviral agent.
    Ohnishi H; Kosuzume H; Inaba H; Okura M; Morita Y; Mochizuki H; Suzuki Y
    Infect Immun; 1982 Oct; 38(1):243-50. PubMed ID: 6183209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunostimulative therapy of herpes zoster (three years' experience with inosiplex) (author's transl)].
    Bunta S; Peris Z
    Z Hautkr; 1981 Nov; 56(22):1457-66. PubMed ID: 6171939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inosiplex in recurrent herpes simplex infections.
    Galli M; Lazzarin A; Moroni M; Zanussi C
    Lancet; 1982 Aug; 2(8293):331-2. PubMed ID: 6178916
    [No Abstract]   [Full Text] [Related]  

  • 13. Antiviral agents.
    Hermans PE; Cockerill FR
    Mayo Clin Proc; 1983 Apr; 58(4):217-22. PubMed ID: 6339831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inosiplex for localized herpes zoster in childhood cancer patients: preliminary controlled study.
    Feldman S; Hayes FA; Chaudhary S; Ossi M
    Antimicrob Agents Chemother; 1978 Sep; 14(3):495-7. PubMed ID: 81655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic control of viral infections: chemotherapy, interferon and gamma globulin.
    St Geme JW
    Curr Probl Pediatr; 1979 Nov; 10(1):1-46. PubMed ID: 94280
    [No Abstract]   [Full Text] [Related]  

  • 16. [Potentiation of cytotoxic effects of 5-fluorouracil by inosiplex on cancer cells].
    Miyoshi T; Ogawa S; Nobuhara M; Namba M
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):440-4. PubMed ID: 6200078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of subacute sclerosing panencephalitis with interferon-alpha, ribavirin, and inosiplex.
    Solomon T; Hart CA; Vinjamuri S; Beeching NJ; Malucci C; Humphrey P
    J Child Neurol; 2002 Sep; 17(9):703-5. PubMed ID: 12503650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recurrent herpes simplex. The situation in the United States].
    Horvath P
    Z Hautkr; 1977 May; 52(9):529-32. PubMed ID: 68631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inosine pranobex--only for use in controlled trials.
    Drug Ther Bull; 1986 Dec; 24(24):95-6. PubMed ID: 2433117
    [No Abstract]   [Full Text] [Related]  

  • 20. Failure of oral inosiplex treatment of recurrent herpes simplex virus infections.
    Kalimo KO; Joronen IA; Havu VK
    Arch Dermatol; 1983 Jun; 119(6):463-7. PubMed ID: 6190441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.